
Column - June 20, 2022
Advice to smaller listed Swedish Life Science companies
Most listed Swedish biotech companies have cash and financing that is sufficient to last until 2023 or longer. The few who do not have this should probably hurry while there is time. During 2023-2025, many companies will return for new funds and competition will be fierce. In addition, there are also many listed diagnostics and […]